These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2841212)

  • 1. Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes.
    Langer SZ; Arbilla S
    Fundam Clin Pharmacol; 1988; 2(3):159-70. PubMed ID: 2841212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes.
    Langer SZ; Arbilla S
    Pharmacol Biochem Behav; 1988 Apr; 29(4):763-6. PubMed ID: 2842809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
    Benavides J; Peny B; Ruano D; Vitorica J; Scatton B
    Brain Res; 1993 Feb; 604(1-2):240-50. PubMed ID: 8096157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.
    Sanger DJ; Benavides J
    Psychopharmacology (Berl); 1993; 111(3):315-22. PubMed ID: 7870969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.
    Sanger DJ; Benavides J; Perrault G; Morel E; Cohen C; Joly D; Zivkovic B
    Neurosci Biobehav Rev; 1994; 18(3):355-72. PubMed ID: 7984354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors.
    Arbilla S; Allen J; Wick A; Langer SZ
    Eur J Pharmacol; 1986 Nov; 130(3):257-63. PubMed ID: 2878820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of [35S]TBPS binding by ligands with preferential affinity for benzodiazepine BZ1 sites in the cerebral cortex of newborn and adult rats.
    Giorgi O; Lecca D; Cancedda E; Serra GP; Corda MG
    Eur J Pharmacol; 1995 Jun; 290(1):37-47. PubMed ID: 7664823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs.
    Langer SZ; Arbilla S; Tan S; Lloyd KG; George P; Allen J; Wick AE
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():103-7. PubMed ID: 1974068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding.
    Wu Y; Rosenberg HC; Chiu TH; Ramsey-Williams V
    J Pharmacol Exp Ther; 1994 Feb; 268(2):675-82. PubMed ID: 8113978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes.
    Piercey MF; Hoffmann WE; Cooper M
    Brain Res; 1991 Jul; 554(1-2):244-52. PubMed ID: 1657289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of typical and atypical benzodiazepines on the central and peripheral benzodiazepine receptors.
    Watanabe Y; Shibuya T; Khatami S; Salafsky B
    Jpn J Pharmacol; 1986 Oct; 42(2):189-97. PubMed ID: 3025490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS.
    Mehta AK; Shank RP
    Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central benzodiazepine receptors in the spinal cord and other regions of the CNS of the cat.
    Luzzani F; Colombo G; Glässer A
    Neuropharmacology; 1984 Oct; 23(10):1137-40. PubMed ID: 6151628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.
    Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
    Behav Pharmacol; 1999 Sep; 10(5):483-95. PubMed ID: 10780255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes.
    Langer SZ; Arbilla S; Benavides J; Scatton B
    Adv Biochem Psychopharmacol; 1990; 46():61-72. PubMed ID: 1981304
    [No Abstract]   [Full Text] [Related]  

  • 17. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
    Massotti M; Schlichting JL; Antonacci MD; Giusti P; Memo M; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1154-60. PubMed ID: 1848629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.
    Byrnes JJ; Greenblatt DJ; Miller LG
    Brain Res Bull; 1992 Dec; 29(6):905-8. PubMed ID: 1361878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue.
    Sanger DJ
    Behav Pharmacol; 1995 Mar; 6(2):116-126. PubMed ID: 11224318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity.
    Griebel G; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):81-98. PubMed ID: 10368858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.